Harbour Investments’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-61
Closed -$1.32K 3481
2024
Q2
$1.32K Sell
61
-60
-50% -$1.26K ﹤0.01% 2930
2024
Q1
$2.68K Hold
121
﹤0.01% 2691
2023
Q4
$3.33K Hold
121
﹤0.01% 2550
2023
Q3
$2.7K Hold
121
﹤0.01% 2475
2023
Q2
$3.08K Hold
121
﹤0.01% 2426
2023
Q1
$2.7K Hold
121
﹤0.01% 2481
2022
Q4
$2.87K Hold
121
﹤0.01% 2421
2022
Q3
$2K Hold
121
﹤0.01% 2493
2022
Q2
$2K Buy
+121
New +$2.44K ﹤0.01% 2493
2021
Q4
$13K Hold
326
﹤0.01% 1837
2021
Q3
$15K Hold
326
﹤0.01% 2462
2021
Q2
$13K Sell
326
-401
-55% -$17.1K ﹤0.01% 2602
2021
Q1
$39K Buy
+727
New +$41.9K ﹤0.01% 1839

Other funds holding VCYT

Harbour Investments's VCYT Position: Q3 2024 in Review

Harbour Investments sold out of Veracyte (VCYT) in Q3 2024, closing a stake of 61 shares — an estimated $1.32K sold.

Harbour Investments first reported a position in VCYT in Q1 2021 and held it in 13 quarters. The position peaked at $39K in Q1 2021. 293 funds tracked by Wall St. Rank hold VCYT as of Q3 2024.

  • Harbour Investments reported no remaining Veracyte position as of Q3 2024 after selling out during the quarter.
  • Harbour Investments sold 61 Veracyte shares in Q3 2024, an estimated $1.32K.
  • Harbour Investments first reported a position in Veracyte in Q1 2021 and held it in 13 quarters.
  • Harbour Investments's Veracyte position peaked at $39K in Q1 2021.
  • 293 funds tracked by Wall St. Rank held Veracyte as of Q3 2024.

Based on Harbour Investments's 13F filing for Q3 2024, filed 4 Nov 2024.